Techniques³

Omics

Omics refers to a family of scientific disciplines in biology that involve the comprehensive, high-throughput characterization and quantification of pools of biological molecules, such as genes, transcripts, proteins, and metabolites, to understand their roles and interactions within living systems. These fields, which include genomics (study of the complete set of genes), transcriptomics (analysis of all RNA transcripts), proteomics (examination of the entire proteome), and metabolomics (profiling of all metabolites), among others like epigenomics and lipidomics, enable global assessments of biological processes rather than targeted analyses of individual components.

Omics refers to the high-throughput, comprehensive analysis of biological molecules or systems on a global scale, encompassing fields such as genomics, transcriptomics, proteomics, and metabolomics, which study the entirety of specific molecular sets rather than individual components.[14] This approach contrasts with traditional reductionist methods in biology, which focus on isolated pathways or single molecules, by aiming to capture the complexity of biological systems through simultaneous measurement of thousands to millions of elements.

Genomics

Genomics is the comprehensive study of an organism’s entire genome, encompassing all of its DNA, including the sequencing, assembly, and annotation of genetic material to understand its structure, organization, and function. This field employs high-throughput DNA sequencing methods, bioinformatics tools, and recombinant DNA techniques to analyze the full genetic complement, generating vast datasets that reveal patterns of genetic variation and organization. Unlike traditional genetics, which focuses on individual genes, genomics examines the genome at a systems level to elucidate how genetic elements interact within the broader context of the organism.[23][24]
Key aspects of genomics include structural genomics, which involves mapping the physical locations of genes and other genomic features to construct detailed genome maps that guide sequencing efforts; functional genomics, which investigates gene functions and expression patterns often through genome-wide association studies (GWAS) that link genetic variants to traits or diseases; and comparative genomics, which compares genomes across species to identify conserved regions indicative of evolutionary relationships and functional elements. These approaches enable the annotation of genomes by assigning biological roles to sequences and highlighting variations such as single nucleotide polymorphisms (SNPs). Briefly, genomics data can integrate with epigenomics to provide insights into how environmental factors influence gene regulation without altering the DNA sequence itself.[25][26][27]
A major milestone in genomics was the completion of the Human Genome Project in April 2003, an international effort that produced the first reference sequence of the human genome, spanning approximately 3 billion base pairs and identifying an estimated 20,000–25,000 genes. This project, coordinated by the U.S. National Institutes of Health and Department of Energy, cost about $3 billion and laid the foundation for subsequent genomic research by demonstrating the feasibility of large-scale sequencing. Since then, technological advances have dramatically reduced sequencing costs; for instance, the price per human genome dropped from around $100 million in 2001 to under $1,000 by 2025, enabling widespread clinical and research applications.[28][29]
Central techniques in genomics include whole-genome sequencing (WGS), which determines the complete DNA sequence of an organism to capture all genetic variations, and SNP arrays, which simultaneously genotype hundreds of thousands of SNPs to detect common variants associated with traits. These methods facilitate genome assembly, where short reads are computationally pieced together to reconstruct the original sequence, and annotation, which identifies genes, regulatory elements, and functional motifs. In applications to hereditary diseases, genomics has revolutionized diagnosis by identifying causative mutations in conditions like cystic fibrosis and Huntington’s disease through WGS and GWAS, enabling personalized risk assessment and targeted therapies.

Transcriptomics

Transcriptomics is the study of the transcriptome, defined as the complete set of all RNA molecules, including messenger RNA (mRNA) and various non-coding RNAs such as long non-coding RNAs (lncRNAs), produced by an organism or in a specific cell or tissue at a given time.^[44] This field focuses on quantifying and analyzing RNA transcripts to understand gene expression dynamics, including how genes are turned on or off in response to developmental cues, environmental stimuli, or disease states.^[45] Unlike genomics, which examines static DNA sequences, transcriptomics captures the dynamic, functional output of the genome, revealing regulatory mechanisms and cellular responses.^[46]The primary technique in transcriptomics is RNA sequencing (RNA-seq), which has become the gold standard by 2025, surpassing older microarray methods due to its superior sensitivity for low-abundance transcripts, broader dynamic range, and ability to detect novel isoforms and non-coding RNAs without prior knowledge of sequences.^[47][48] RNA-seq involves reverse transcription of RNA to complementary DNA (cDNA), followed by high-throughput sequencing, enabling comprehensive profiling of the entire transcriptome.^[49] For higher resolution, single-cell RNA-seq (scRNA-seq) techniques isolate and sequence transcripts from individual cells, uncovering heterogeneity within tissues and identifying rare cell types or transient states that bulk methods overlook.^[50][51]Key insights from transcriptomics include the prevalence of alternative splicing, where a single gene produces multiple mRNA isoforms through differential exon inclusion, affecting up to 95% of multi-exon genes in humans and expanding proteome diversity.^[52] LncRNAs, often identified through RNA-seq, play crucial regulatory roles, such as modulating splicing factors, acting as scaffolds for protein complexes, or influencing chromatin structure to control gene expression.^[53] These findings have driven applications in biomarker discovery, where transcriptomic profiles identify dysregulated genes and pathways in diseases like cancer, enabling the development of diagnostic signatures from patient samples.^[54][55]Data analysis in transcriptomics typically begins with alignment of sequencing reads to a reference genome, followed by quantification of transcript abundance using tools like featureCounts or Salmon.^[56] Differential expression analysis compares transcript levels between conditions, employing statistical models such as DESeq2, which uses negative binomial distribution to detect significant changes while accounting for variability and normalizing for library size.^[57] For isoform-level insights, methods like DELongSeq or NanoCount enable precise quantification of alternative splicing events by estimating uncertainty in expression levels from sequencing data.

Proteomics

Proteomics is the large-scale study of the proteome, defined as the complete set of proteins expressed by a cell, tissue, or organism under specific conditions, encompassing their structures, abundances, modifications, and interactions.^[60] Unlike genomics, which focuses on static DNA sequences, proteomics captures dynamic aspects such as post-translational modifications (PTMs) like phosphorylation, glycosylation, and ubiquitination, which vastly expand protein functional diversity and cannot be inferred from the genome alone.^[61] These PTMs regulate protein activity, localization, and interactions, enabling the proteome to respond to environmental cues and developmental signals in ways not predictable from transcriptomic data.^[62]Central to proteomics are analytical methods that enable high-throughput protein identification and characterization. Two-dimensional gel electrophoresis (2D-GE) separates proteins based on isoelectric point and molecular weight, allowing visualization and quantification of thousands of proteins in complex mixtures, though it struggles with hydrophobic or low-abundance species.^[63] Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) has become the cornerstone for proteomic analysis, providing sensitive detection and sequencing of peptides for database matching and de novo identification.^[64] Proteomics workflows are broadly classified into bottom-up and top-down approaches: bottom-up proteomics digests proteins into peptides for easier fragmentation and analysis, facilitating large-scale profiling but potentially losing information on PTM stoichiometry; top-down proteomics examines intact proteins to preserve full modification patterns and isoforms, though it faces challenges in ionization efficiency for larger molecules.^[65]In biomedical applications, proteomics excels at identifying drug targets by mapping protein expression changes in disease states, such as overexpressed kinases in cancer that can be inhibited therapeutically.^[66] A key strength lies in PTM mapping, exemplified by phosphoproteomics, which elucidates signaling cascades where phosphorylation events activate or deactivate pathways like MAPK in cell proliferation and apoptosis.^[67] These insights have driven precision medicine, such as targeting phosphorylated EGFR variants in lung cancer therapies.Despite advances, proteomics faces challenges from protein instability, including degradation during sample handling and the wide dynamic range of protein abundances that masks low-level species critical for signaling.^[60] Membrane proteins, with their hydrophobic nature, are particularly prone to aggregation and poor solubility, complicating extraction and analysis.^[63] By 2025, AI-driven tools like AlphaFold3 have transformed the field by predicting protein structures and PTM effects with near-experimental accuracy, accelerating functional annotation and interaction modeling without relying solely on empirical data.

Metabolomics

Metabolomics is the systematic study of the metabolome, which comprises the complete set of small-molecule metabolites—typically under 1,500 Da—present in a biological system, such as cells, tissues, or biofluids.[69] This field captures the end products of cellular processes, providing a direct reflection of the physiological or pathological state of an organism, and is considered the omics discipline closest to the phenotype due to its integration of genetic, environmental, and lifestyle influences.[70] Unlike genomics or proteomics, which focus on potential or intermediary layers, metabolomics reveals functional outcomes, such as responses to disease, diet, or drugs, making it essential for understanding dynamic biological responses.[71]
The primary analytical techniques in metabolomics include nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS)-based methods, each offering complementary strengths in metabolite detection and quantification.[72] NMR provides non-destructive, reproducible structural information without extensive sample preparation, ideal for identifying known metabolites in complex mixtures, though it has lower sensitivity for low-abundance compounds.[9] MS, often coupled with chromatography like liquid chromatography (LC-MS) or gas chromatography (GC-MS), excels in high-throughput, sensitive detection of a broader metabolite range, enabling the profiling of hundreds to thousands of compounds per sample.[72] Approaches are classified as untargeted, which aim for comprehensive, hypothesis-generating profiling of all detectable metabolites without prior selection, or targeted, which focus on predefined sets of metabolites for precise quantification and validation.[73]
An extension of metabolomics, fluxomics incorporates isotopic labeling to measure the dynamic rates of metabolic fluxes through pathways, revealing how metabolites are transformed over time rather than static snapshots.[74] This approach uses stable isotopes like 13C to trace flux distribution, providing insights into metabolic network regulation and enzyme kinetics that static metabolomics alone cannot capture.[75] Fluxomics thus bridges metabolomics with systems biology, enabling the modeling of pathway efficiencies in response to perturbations.[76]
Metabolomics plays a key role in elucidating metabolic pathways by mapping metabolite alterations to specific biochemical routes, such as identifying disruptions in glycolysis or the tricarboxylic acid cycle in diseased states.[77] Proteomic influences, including enzyme expression levels, can modulate these pathways, linking protein activity to observed metabolite changes.[78] In biomarker discovery, metabolomics has identified signatures for diseases like type 2 diabetes, where elevated branched-chain amino acids and reduced lysophosphatidylcholines serve as predictive indicators of insulin resistance years before clinical onset.[79] These applications extend to clinical diagnostics, with targeted panels validating metabolites like acylcarnitines for monitoring therapeutic responses.[80]
As of 2025, emerging trends in metabolomics emphasize integration with wearable technologies for real-time monitoring, such as non-invasive sweat or urine sensors that detect metabolite fluctuations during daily activities.[81] This fusion enables continuous profiling of markers like glucose or lactate, supporting personalized interventions in metabolic disorders and advancing precision health.

Genetic Screens & Tools

Dissections and Immunohistochemistry

ChIP and ENCODE

sleep research, Autism, TBI, neurodegenerative